White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients

NeuroImage

Volumn 47, Issue 4, 2009, Pages 1154-1162

  Chen, Yasheng ^a   An, Hongyu ^a   Zhu, Hongtu ^b   Stone, Taylor ^a   Smith, J Keith ^a   Hall, Colin ^a   Bullitt, Elizabeth ^a   Shen, Dinggang ^a   Lin, Weili ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANISOTROPY; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CAPSULA INTERNA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMENTIA; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL LOBE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMAGE ANALYSIS; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; RANK SUM TEST; TEMPORAL LOBE; WHITE MATTER;

ADULT; DEMENTIA; DEMYELINATING DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HIV INFECTIONS; HUMANS; MALE; NERVE FIBERS, MYELINATED;

EID: 67651154137     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.04.030     Document Type: Article

References (42)

1. AIDSTaskForce. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41 (1991) 778-785
2. Albright A.V., Soldan S.S., and Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 9 (2003) 222-227
3. An S.F., and Scaravilli F. Early HIV-1 infection of the central nervous system. Arch. Anat. Cytol. Pathol. 45 (1997) 94-105
4. Aylward E.H., Brettschneider P.D., McArthur J.C., Harris G.J., Schlaepfer T.E., Henderer J.D., Barta P.E., Tien A.Y., and Pearlson G.D. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am. J. Psychiatry 152 (1995) 987-994
5. Aylward E.H., Henderer J.D., McArthur J.C., Brettschneider P.D., Harris G.J., Barta P.E., and Pearlson G.D. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43 (1993) 2099-2104
6. Basser P.J., Mattiello J., and LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson., Ser. B 103 (1994) 247-254
7. Chang L., Ernst T., Leonido-Yee M., Witt M., Speck O., Walot I., and Miller E.N. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53 (1999) 782-789
8. Chiang M.C., Dutton R.A., Hayashi K.M., Lopez O.L., Aizenstein H.J., Toga A.W., Becker J.T., and Thompson P.M. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 34 (2007) 44-60
9. Cloak C.C., Chang L., and Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J. Neuroimmunol. 157 (2004) 147-152
10. Dore G.J., Correll P.K., Li Y., Kaldor J.M., Cooper D.A., and Brew B.J. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 13 (1999) 1249-1253
11. Filippi C.G., Ulug A.M., Ryan E., Ferrando S.J., and van Gorp W. Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain. [see comment]. Ajnr: Am. J. Neuroradiol. 22 (2001) 277-283
12. Giometto B., An S.F., Groves M., Scaravilli T., Geddes J.F., Miller R., Tavolato B., Beckett A.A., and Scaravilli F. Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann. Neurol. 42 (1997) 34-40
13. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5 (2005) 69-81
14. Gray F., Belec L., Chretien F., Dubreuil-Lemaire M.L., Ricolfi F., Wingertsmann L., Poron F., and Gherardi R. Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol. Appl. Neurobiol. 24 (1998) 209-216
15. Gray F., Chretien F., Vallat-Decouvelaere A.V., and Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J. Neuropathol. Exp. Neurol. 62 (2003) 429-440
16. Gray F., Lescs M.C., Keohane C., Paraire F., Marc B., Durigon M., and Gherardi R. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J. Neuropathol. Exp. Neurol. 51 (1992) 177-185
17. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J., and Lantos P. Neuropathology of early HIV-1 infection. Brain Pathol. 6 (1996) 1-15
18. Kabani N., J.D.M., Holmes C.J., and Evans A.C. A 3D atlas of the human brain. Neuroimage 7 (1998) S717
19. Kraus M.F., Susmaras T., Caughlin B.P., Walker C.J., Sweeney J.A., and Little D.M. White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain 130 (2007) 2508-2519
20. Langford T.D., Letendre S.L., Larrea G.J., and Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 13 (2003) 195-210
21. Liuzzi G.M., Mastroianni C.M., Vullo V., Jirillo E., Delia S., and Riccio P. Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex. J. Neuroimmunol. 36 (1992) 251-254
22. Masliah E., DeTeresa R.M., Mallory M.E., and Hansen L.A. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. Aids 14 (2000) 69-74
23. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., Jacobson L.P., et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43 (1993) 2245-2252
24. Medana I.M., and Esiri M.M. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126 (2003) 515-530
25. Moroni M., and Antinori S. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era. Aids 17 Suppl 1 (2003) S51-64
26. Pomara N., Crandall D.T., Choi S.J., Johnson G., and Lim K.O. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 106 (2001) 15-24
27. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., and Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239 (1988) 586-592
28. Ragin A.B., Storey P., Cohen B.A., Edelman R.R., and Epstein L.G. Disease burden in HIV-associated cognitive impairment: a study of whole-brain imaging measures. Neurology 63 (2004) 2293-2297
29. Ragin A.B., Storey P., Cohen B.A., Epstein L.G., and Edelman R.R. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am. J. Neuroradiol. 25 (2004) 195-200
30. Ragin A.B., Wu Y., Storey P., Cohen B.A., Edelman R.R., and Epstein L.G. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J. Neurovirol. 11 (2005) 292-298
31. Raja F., Sherriff F.E., Morris C.S., Bridges L.R., and Esiri M.M. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol. (Berl) 93 (1997) 184-189
32. Shen D., and Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans. Med. Imaging 21 (2002) 1421-1439
33. Shen D., and Davatzikos C. Very high-resolution morphometry using mass-preserving deformations and HAMMER elastic registration. Neuroimage 18 (2003) 28-41
34. Song S.K., Sun S.W., Ramsbottom M.J., Chang C., Russell J., and Cross A.H. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17 (2002) 1429-1436
35. Stebbins G.T., Smith C.A., Bartt R.E., Kessler H.A., Adeyemi O.M., Martin E., Cox J.L., Bammer R., and Moseley M.E. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study. J. Acquir. Immune. Defic. Syndr. 46 (2007) 564-573
36. Sun S.W., Liang H.F., Trinkaus K., Cross A.H., Armstrong R.C., and Song S.K. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn. Reson. Med. 55 (2006) 302-308
37. Sundgren P.C., Dong Q., Gomez-Hassan D., Mukherji S.K., Maly P., and Welsh R. Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 46 (2004) 339-350
38. Thurnher M.M., Castillo M., Stadler A., Rieger A., Schmid B., and Sundgren P.C. Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am. J. Neuroradiol. 26 (2005) 2275-2281
39. Westin C.F., Maier S.E., Mamata H., Nabavi A., Jolesz F.A., and Kikinis R. Processing and visualization for diffusion tensor MRI. Med. Image. Anal. 6 (2002) 93-108
40. Wu Y., Storey P., Cohen B.A., Epstein L.G., Edelman R.R., and Ragin A.B. Diffusion alterations in corpus callosum of patients with HIV. AJNR Am. J. Neuroradiol. 27 (2006) 656-660
41. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20 (2001) 45-57
42. Zhu H., JG I., NS T., R D., X H., R B., and Peterson B.S. A statistical analysis of brain morphology using wild bootstrapping. IEEE Trans. Med. Imaging 26 (2007) 954-966